MENU
RARE
AS OF
Nov 13 closing price
Price
$32.90
Change
-$0.63 (-1.88%)
Capitalization
3.18B
90 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RARE is expected to report earnings to fall 35.91% to -115 cents per share on February 12

Ultragenyx Pharmaceutical RARE Stock Earnings Reports
Q4'25
Est.
$-1.16
Q3'25
Missed
by $0.58
Q2'25
Beat
by $0.13
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.05
The last earnings report on November 04 showed earnings per share of -180 cents, missing the estimate of -123 cents. With 1.26M shares outstanding, the current market capitalization sits at 3.18B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RARE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RARE showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RARE
A.I. Advisor
published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com